MS and Tysabri related PML: the real facts
In this video I discuss Tysabri-related Progressive Multifocal Leukoencephalopathy (PML), a demyelinating infection caused by the John Cunningham virus (JCV). I explain what PML is, what causes it, and the risk factors for PML infection associated with taking Tysabri for Multiple Sclerosis If you have questions about PML, then start watching this video now! *********************************************************** FOLLOW on Twitter: / aaronbostermd FRIEND on Facebook: / aaronbostermd SUBSCRIBE on YouTube: / aaronbostermd VISIT US on the web: https://bosterms.com/ VISIT us on web: BosterMS.com *********************************************************** NOTE: Make sure to talk to your provider before ANY treatment decision. We hope to educate, empower and energize those impacted by Multiple Sclerosis. This channel consists of a collection of formal lectures and informal video clips about MS to help education others. These videos do not provide medical advice and are for informational/educational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any of our videos. They are just to help educate you about the condition guys!

Tysabri PML Risk & Extended Interval Dosing

Should We Still Use Aubagio to Treat Multiple Sclerosis?

Rare and Unusual MS Symptoms (I've seen in clinic)

This New Histamine Treatment Helped 89% of Patients

Cognitive Impairment: Multiple Sclerosis Symptoms Confuse Friends and Family

How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others

Consultant Visit | Aggressive MS | Tysabri Ocrevus | JC Virus and PML

Mini-Lecture Series: Progressive Multifocal Leukoencephalopathy (PML)

PML and JC

My Tecfidera Experience

Why Worse? A Multiple Sclerosis Neurologist Explains

Tysabri: PML Risk Thought Experiment

Mavenclad (Cladribine) for Multiple Sclerosis Explained by Neurologist

𝐂𝐚𝐬𝐞 𝐬𝐭𝐮𝐝𝐲 𝟏𝟕𝟐 | Progressive Multifocal Leukoencephalopathy | explained by Dr. Betsy Grunch

Risk of B-Cell Depleters Long-Term (Ocrevus, Rituximab, Kesimpta, Briumvi)

'All of them took BOOSTERS': Witness’ explosive claim linking mRNA COVID vaccines to cancer relapse

What You Need to Know About Natalizumab (Tysabri®)

Finding the Right Treatment for PML

Multiple Sclerosis - B Cell Depleting Medications - Q&A

